These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16168367)

  • 21. Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt's lymphoma tumorigenesis can be enhanced.
    Wiseman A
    Med Hypotheses; 2006; 66(5):1046-7. PubMed ID: 16413684
    [No Abstract]   [Full Text] [Related]  

  • 22. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
    Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
    Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer biology: can less be more for p53?
    Berns A
    Nature; 2006 Sep; 443(7108):153-4. PubMed ID: 16971934
    [No Abstract]   [Full Text] [Related]  

  • 24. Wild-type p53 in cancer cells: when a guardian turns into a blackguard.
    Kim E; Giese A; Deppert W
    Biochem Pharmacol; 2009 Jan; 77(1):11-20. PubMed ID: 18812169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of class II beta-tubulin expression by tumor suppressor p53 protein in mouse melanoma cells in response to Vinca alkaloid.
    Arai K; Matsumoto Y; Nagashima Y; Yagasaki K
    Mol Cancer Res; 2006 Apr; 4(4):247-55. PubMed ID: 16603638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 splice variants generated by atypical mRNA processing confer complexity of p53 transcripts in the human brain.
    Nikoshkov A; Hurd YL
    Biochem Biophys Res Commun; 2006 Dec; 351(2):383-6. PubMed ID: 17070776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternatively spliced p53 isoforms: alternative views or alternative functions?
    Deppert W
    Cell Cycle; 2009 Jun; 8(11):1645. PubMed ID: 19448432
    [No Abstract]   [Full Text] [Related]  

  • 29. DNA double-strand break repair activities in mammary epithelial cells--influence of endogenous p53 variants.
    Keimling M; Wiesmüller L
    Carcinogenesis; 2009 Jul; 30(7):1260-8. PubMed ID: 19429664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
    Hrstka R; Powell DJ; Kvardova V; Roubalova E; Bourougaa K; Candeias MM; Sova P; Zak F; Fåhraeus R; Vojtĕsek B
    Anticancer Drugs; 2008 Apr; 19(4):369-79. PubMed ID: 18454047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcription regulation by mutant p53.
    Weisz L; Oren M; Rotter V
    Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum Concept.
    Uversky VN
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant p53: an oncogenic transcription factor.
    Strano S; Dell'Orso S; Di Agostino S; Fontemaggi G; Sacchi A; Blandino G
    Oncogene; 2007 Apr; 26(15):2212-9. PubMed ID: 17401430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel IL-15 isoforms generated by alternative splicing are expressed in the intestinal epithelium.
    Tan X; Lefrançois L
    Genes Immun; 2006 Jul; 7(5):407-16. PubMed ID: 16791279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism.
    Clere N; Bermont L; Fauconnet S; Lascombe I; Saunier M; Vettoretti L; Plissonnier ML; Mougin C
    Exp Cell Res; 2007 Sep; 313(15):3239-50. PubMed ID: 17678892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.
    Yu DH; Fan W; Liu G; Nguy V; Chatterton JE; Long S; Ke N; Meyhack B; Bruengger A; Brachat A; Wong-Staal F; Li QX
    Exp Cell Res; 2006 Apr; 312(6):865-76. PubMed ID: 16413018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple isoforms of the tumor suppressor myopodin are simultaneously transcribed in cancer cells.
    De Ganck A; De Corte V; Staes A; Gevaert K; Vandekerckhove J; Gettemans J
    Biochem Biophys Res Commun; 2008 May; 370(2):269-73. PubMed ID: 18371299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of the tumor suppressor ARF in oncogenesis].
    Pimkina IuS; Dorosevich AE
    Arkh Patol; 2009; 71(1):60-3. PubMed ID: 19514363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53--integrating the complexity.
    Hall PA; Meek D; Lane DP
    J Pathol; 1996 Sep; 180(1):1-5. PubMed ID: 8943807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.